UBS AM’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.2M | Buy |
200,260
+60,169
| +43% | +$963K | ﹤0.01% | 1930 |
|
|
2025
Q1 | $2.39M | Sell |
140,091
-139,161
| -50% | -$2.38M | ﹤0.01% | 1900 |
|
|
2024
Q4 | $6.92M | Sell |
279,252
-31,578
| -10% | -$782K | ﹤0.01% | 1440 |
|
|
2024
Q3 | $8.86M | Sell |
310,830
-9,678
| -3% | -$276K | ﹤0.01% | 1291 |
|
|
2024
Q2 | $8.46M | Buy |
320,508
+114,477
| +56% | +$3.02M | ﹤0.01% | 1213 |
|
|
2024
Q1 | $6.66M | Sell |
206,031
-1,521
| -0.7% | -$49.1K | ﹤0.01% | 1144 |
|
|
2023
Q4 | $8.74M | Buy |
207,552
+124,636
| +150% | +$5.25M | ﹤0.01% | 1042 |
|
|
2023
Q3 | $3.18M | Buy |
82,916
+31,194
| +60% | +$1.2M | ﹤0.01% | 1400 |
|
|
2023
Q2 | $802K | Hold |
51,722
| – | – | ﹤0.01% | 2104 |
|
|
2023
Q1 | $802K | Buy |
51,722
+7,968
| +18% | +$124K | ﹤0.01% | 2104 |
|
|
2022
Q4 | $777K | Buy |
43,754
+6,409
| +17% | +$114K | ﹤0.01% | 1982 |
|
|
2022
Q3 | $208K | Sell |
37,345
-14,597
| -28% | -$81.5K | ﹤0.01% | 2599 |
|
|
2022
Q2 | $203K | Hold |
51,942
| – | – | ﹤0.01% | 2578 |
|
|
2022
Q1 | $286K | Hold |
51,942
| – | – | ﹤0.01% | 2610 |
|
|
2021
Q4 | $443K | Hold |
51,942
| – | – | ﹤0.01% | 2601 |
|
|
2021
Q3 | $451K | Sell |
51,942
-8,255
| -14% | -$71.7K | ﹤0.01% | 2537 |
|
|
2021
Q2 | $636K | Buy |
60,197
+16,650
| +38% | +$176K | ﹤0.01% | 2440 |
|
|
2021
Q1 | $698K | Sell |
43,547
-1,094
| -2% | -$17.5K | ﹤0.01% | 2256 |
|
|
2020
Q4 | $2.06M | Buy |
44,641
+24,641
| +123% | +$1.14M | ﹤0.01% | 1672 |
|
|
2020
Q3 | $704K | Buy |
20,000
+11,100
| +125% | +$391K | ﹤0.01% | 1977 |
|
|
2020
Q2 | $217K | Buy |
+8,900
| New | +$217K | ﹤0.01% | 2370 |
|